Katalyst CRO ยท 2 months ago
GMP Senior Auditor
Katalyst CRO is seeking a GMP Senior Auditor to ensure compliance with cGMP, regulatory requirements, and company quality standards. This role involves planning, conducting, and reporting on audits while supporting the Pharmaceutical Quality System by identifying gaps and driving continuous improvement.
AnalyticsBiopharmaData ManagementHuman ResourcesQuality Assurance
Responsibilities
Conduct routine, for-cause, and risk-based audits of internal processes, RPT CMOs, and suppliers
Prepare detailed audit plans, checklists, and schedules
Ensure adherence to FDA, EMA, ICH, and other applicable regulatory guidelines
Review and approve deviations, CAPAs, and change controls
Document audit observations and issue formal audit reports
Track and verify implementation of corrective and preventive actions (CAPAs)
Provide guidance on compliance requirements and audit readiness
Support regulatory inspections and customer audits
Identify systemic issues and recommend process improvements
Stay updated on evolving regulatory requirements and industry best practices
Qualification
Required
Must Have Radiopharmaceuticals and Quality experience
Bachelor's degree in Life Sciences, Pharmacy, or related field
35 years in Radio Pharmaceuticals, with at least 2 years in auditing
Strong knowledge of RPT cGMP, GDP, and global regulatory requirements
Excellent attention to detail and analytical skills
Strong communication and report-writing abilities
Ability to travel (up to 10%) for audits
Preferred
ASQ Certified Quality Auditor (CQA)
ISO 9001 Lead Auditor
GCP/GMP auditing certifications
Company
Katalyst CRO
Katalyst CRO | Advancing Healthcare & Life Sciences with Expert Research & Regulatory Solutions Katalyst Healthcare & Life Sciences (Katalyst CRO) is a Global Contract Research and Knowledge Process Outsourcing Organization (CRO) dedicated to driving innovation in research, regulatory compliance, and quality excellence for pharmaceutical, biotechnology, and medical device companies worldwide.
Funding
Current Stage
Growth StageRecent News
2024-04-07
Company data provided by crunchbase